regulation

ASA bans dopamine patch ad over unproven mood claims

The ASA has banned a Kind Patches Instagram advert for a supplement patch, ruling its dopamine and mood claims unsubstantiated and the advert irresponsible

Printed regulatory documents on a desk

The Advertising Standards Authority banned a paid Instagram advert for Kind Patches Ltd on 2 September 2026, ruling that claims made for a supplement patch were misleading and that the advert itself was irresponsible. The advert, seen on 29 April 2026, promoted what it called the new Dopamine Patch and said the product improved mood, focus and motivation by raising dopamine and serotonin levels. The ASA said consumers would take that to mean the patch contained dopamine or increased dopamine in the body. According to the ruling, the company did not hold evidence to substantiate the claimed health benefits, and it renamed the product after the complaint was made. A second point was upheld because the advert showed a patch being applied to another person without their knowledge, which the ASA judged irresponsible given that the recipient had not consented and could react badly to it. The ruling cites CAP Code rules 1.3, 3.1, 3.7 and 4.4, and says the advert must not appear again in the form complained of.

The second upheld ruling against the company in five weeks

Aesthetics Journal reported on 31 July 2026 that the ASA had already upheld a separate complaint about a Facebook advert for a Kind Patches product marketed as a GLP-1 Patch. That earlier ruling found the advert implied the supplement worked like a prescription GLP-1 medicine, and that it was irresponsible because it appeared to address breastfeeding mothers looking to lose weight. The company told the ASA that the product had been withdrawn from sale, that the advert had been produced by a third-party affiliate, and that it had revised its approval process. The two rulings concern different products and different adverts, but the same regulator.

What this means for your supplement routine

Nothing here changes what any nutrient does. It changes what a seller is allowed to say about one. In Great Britain, only health claims on the GB Nutrition and Health Claims Register may be used, and no food supplement may be presented as able to treat, prevent or cure a disease. Northern Ireland continues to follow the EU register, so the authorised wording can differ. A product name that describes a body chemical is not evidence that the product contains it or affects it, and the ASA treats the name as part of the claim. Perqen sets out how its pricing and catalogue work in the membership FAQs.

How Perqen members save

Perqen membership costs 4.99 pounds a month or 29.99 pounds a year and applies member pricing across the full catalogue of stocked brands. This article concerns an advertising ruling against another company and mentions no product we sell.

This article reports published news and research and is for information only. Food supplements are not a substitute for a varied diet or medical care, and no product mentioned is intended to diagnose, treat, cure or prevent any disease. Speak to your GP or pharmacist before changing what you take, especially if you are pregnant, breastfeeding, or taking prescribed medicines.

Sources